PPLPHARMA
NSEF&OPiramal Pharma Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹163.85
2.54 (1.57%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹21.78K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹132.3+23.8%
52W High₹220.85-25.8%
Current Price
₹163.85
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹131.08
Upper Circuit₹196.62
Reference Price
₹163.85
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹166.44
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹168.36
Trend: Price below most MAs — downtrend
Composite score -35.7 (SELL) with 77.0% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
77%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend
EMA20
168.29
EMA50
165.1
EMA200
173.25
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows5
Lower Highs6
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹165.84
₹170.19
₹181.24
₹185.08
₹187.00
Support (Below)
₹160.54
₹156.14
₹148.31
₹145.00
₹134.60
Volume Analysis
TrendDECREASING
Change-10.70%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹162.21
3% Risk₹158.93
5% Risk₹155.66
7% Risk (Custom)
₹152.38Technical Levels
1x ATR (Volatility)₹157.64
2x ATR (Swing)₹151.43
3x ATR (Trend)₹145.22
Immediate Support₹160.54
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹2,204.2 Cr | ₹2,663.9 Cr | ₹1,933.7 Cr | ₹2,139.9 Cr |
| Net Profit | ₹3.7 Cr | ₹153.5 Cr | ₹-81.7 Cr | ₹-136.2 Cr |
| EPS | ₹0.03 | — | ₹-0.62 | ₹-1.03 |
| Operating Profit | ₹366.9 Cr | ₹615.6 Cr | ₹204.4 Cr | ₹208.1 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 16 Jul 2025 | Dividend - Re 0.14 Per Share | DIVIDEND |
| 12 Jul 2024 | Dividend - Rs 0.11 Per Share | DIVIDEND |
| 02 Aug 2023 | Rights 5:46 @ Premium Rs 71/- | RIGHTS_ISSUE |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for PPLPHARMA
View AllNEWS
positive
Business Standard - Markets 11d ago
Piramal Pharma Ltd drops for fifth straight session
Piramal Pharma Ltd is quoting at Rs 165.7, down 3.04% on the day as on 13:19 IST on the NSE. The stock jumped 2.13% in last one year as compared to a 4.38% slide in NIFTY and a 11.99% spurt in the Nifty Pharma index.
AONELIQUIDAONENIFTYAONETMMQ50AONETOTALBANKIETFPHARMABEESPPLPHARMAPVTBANIETFFinancial ServicesFINANCIAL SERVICES
neutral
CNBC TV18 - Markets 26d ago
Piramal Pharma receives EIR from USFDA for Telangana facility
Piramal Pharma said USFDA has closed its inspection of the company's Digwal, Telangana plant with an EIR.
PPLPHARMAHealthcare
NEWS
positive
Business Standard - Markets 33d ago
Piramal Pharma's Sellersville unit gets Form-483 with three observations from US FDA
Piramal Pharma said that the United States Food and Drug Administration (US FDA) has issued a Form-483 with three observations to the company's Sellersville-based facility post an inspection.
PPLPHARMAHealthcare